Bioverge

Bioverge

San Francisco, Californiabioverge.com

Overview

Bioverge is a venture capital firm and investment platform founded in 2016 that specializes in early-stage healthcare startups operating at the intersection of biology and technology. The firm provides accredited investors with access to curated investment opportunities through deal-by-deal investments, diversified access funds, and thematic funds focused on specific disease areas. Bioverge's mission is to democratize access to healthcare investing, funding visionary entrepreneurs and allowing individuals to invest in companies tackling significant health challenges. It also operates an equity crowdfunding platform, Bioverge Portal, to include non-accredited investors.

Portfolio Companies

11

Investments

CompanyDateStageLead
UBERDOCJul 2024SeedLead
My Diabetes TutorJul 2023SeedCo-investor
Repair BiotechnologiesJun 2023Series ACo-investor
Modulo BioJun 2023SeedCo-investor
GigaMuneMay 2023Pre SeedCo-investor

Key People

Neil Littman

Founder General Partner

Rick Gibb

Co-Founder Investment Partner COO

Cody J. Locke

Investor

Parth Amin

Investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSan Francisco, California
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.